Publications

Venook AP. Testing the water before diving off the cutting edge. Annals of surgical oncology. 2003. PMID: 12734077


Small EJ, Halabi S, Dalbagni G, Pruthi R, Phillips G, Edelman M, Bajorin D, Cancer and Leukemia Group B. Overview of bladder cancer trials in the Cancer and Leukemia Group B. Cancer. 2003. PMID: 12673701


Daniel D, Meyer-Morse N, Bergsland EK, Dehne K, Coussens LM, Hanahan D. Immune enhancement of skin carcinogenesis by CD4+ T cells. The Journal of experimental medicine. 2003. PMID: 12695493


Halabi S, Small EJ, Kantoff PW, Kattan MW, Kaplan EB, Dawson NA, Levine EG, Blumenstein BA, Vogelzang NJ. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003. PMID: 12663709


Bivona TG, Philips MR. Ras pathway signaling on endomembranes. Current opinion in cell biology. 2003. PMID: 12648668


Rugo HS. Management of breast cancer diagnosed during pregnancy. Current treatment options in oncology. 2003. PMID: 12594943


Ramirez JJ, Caldwell JL, Majure M, Wessner DR, Klein RL, Meyer EM, King MA. Adeno-associated virus vector expressing nerve growth factor enhances cholinergic axonal sprouting after cortical injury in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2003. PMID: 12684466


Huron DR, Gorre ME, Kraker AJ, Sawyers CL, Rosen N, Moasser MM. A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003. PMID: 12684394


Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. American journal of human genetics. 2003. PMID: 12658575


Mackewicz CE, Wang B, Metkar S, Richey M, Froelich CJ, Levy JA. Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. Blood. 2003. PMID: 12649153


Buzdar A, O'Shaughnessy JA, Booser DJ, Pippen JE, Jones SE, Munster PN, Peterson P, Melemed AS, Winer E, Hudis C. Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003. PMID: 12637464


Gaensler KM, Zhang Z, Lin C, Yang S, Hardt K, Flebbe-Rehwaldt L. Sequences in the (A)gamma-delta intergenic region are not required for stage-specific regulation of the human beta-globin gene locus. Proceedings of the National Academy of Sciences of the United States of America. 2003. PMID: 12629213


Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003. PMID: 12628186


Mackewicz CE, Craik CS, Levy JA. The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 2003. PMID: 12624186


Halabi S, Small EJ, Hayes DF, Vogelzang NJ, Kantoff PW. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003. PMID: 12560440


Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS. Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biological chemistry. 2003. PMID: 12675519


Stone C, McCabe N, Ashworth A. X-chromosome inactivation: X marks the spot for BRCA1. Current biology : CB. 2003. PMID: 12546807


Levy JA. Is HIV superinfection worrisome? Lancet (London, England). 2003. PMID: 12531573


Blackstock AW, Tepper JE, Niedwiecki D, Hollis DR, Mayer RJ, Tempero MA. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas. International journal of gastrointestinal cancer. 2003. PMID: 15361643


Rini BI, Weinberg V, Bok R, Small EJ. Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003. PMID: 12506177